Securities Code: 002294 Securities Abbreviation: Salubris Number: 2026-046
Shenzhen Salubris Pharmaceuticals Co., Ltd. Announcement on the Implementation of the 2025 Equity Distribution Plan
The Company and the entire Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or material omissions.
Shenzhen Salubris Pharmaceuticals Co., Ltd. (hereinafter referred to as the "Company" or "this Company") announces that its 2025 annual equity distribution plan was approved by the 2025 Annual Shareholders' Meeting held on May 11, 2026. The matters concerning equity distribution are hereby announced as follows:
I.情况 of Shareholders' Meeting Approval of Profit Distribution Plan